Detalhe da pesquisa
1.
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 401(10391): 1853-1865, 2023 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37075781
2.
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Gastroenterology
; 164(1): 72-88.e18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36108710
3.
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
Hepatology
; 77(3): 774-788, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908246
4.
The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results.
Future Oncol
; 20(1): 5-16, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916267
5.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(12): 1399-1410, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039993
6.
Combination immunotherapy for hepatocellular carcinoma.
J Hepatol
; 79(2): 506-515, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36933770
7.
Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
J Hepatol
; 78(1): 133-141, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36341767
8.
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.
N Engl J Med
; 382(20): 1894-1905, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32402160
9.
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summary.
Future Oncol
; 19(7): 489-498, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892508
10.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914889
11.
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.
J Hepatol
; 76(4): 862-873, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34902530
12.
Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non-Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.
Oncologist
; 27(12): e938-e948, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190331
13.
Circulating Tumor Cell-Based Messenger RNA Scoring System for Prognostication of Hepatocellular Carcinoma: Translating Tissue-Based Messenger RNA Profiling Into a Noninvasive Setting.
Liver Transpl
; 28(2): 200-214, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34664394
14.
Evolution of Systemic Therapy for Hepatocellular Carcinoma.
Hepatology
; 73 Suppl 1: 150-157, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380571
15.
Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(7): 991-1001, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051880
16.
Comparative effectiveness of first-line palbociclib plus letrozole versus letrozole alone for HR+/HER2- metastatic breast cancer in US real-world clinical practice.
Breast Cancer Res
; 23(1): 37, 2021 03 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33761995
17.
Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
Cancer
; 127(6): 865-874, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231873
18.
Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab.
Br J Cancer
; 124(8): 1388-1397, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531690
19.
Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3.
Oncologist
; 26(7): e1143-e1155, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33955129
20.
Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up.
Oncologist
; 26(5): e749-e755, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33486783